{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-008116","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.310428+00:00","generated_at":"2026-05-26T04:30:22.682295+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NanoVibronix stockholders approve reverse stock split (1:2 to 1:11) and warrant issuance at special meeting","bullets":["Reverse stock split approved: 1,560,759 for, 674,302 against; board may set ratio between 1-for-2 and 1-for-11.","Issuance of shares underlying warrants from Jan 7 Exchange Agreement approved: 417,111 for, 290,431 against, with 1,528,273 broker non-votes.","Adjournment proposal approved but not needed as sufficient votes existed for both proposals.","Record date Jan 17, 2025; 6,138,028 shares outstanding; 2,242,618 votes present at meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-008116","json":"https://secwatch.observer/filing/0001493152-25-008116.json","markdown":"https://secwatch.observer/filing/0001493152-25-008116.md","text":"https://secwatch.observer/filing/0001493152-25-008116.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225008116/0001493152-25-008116-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225008116/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T04:30:22.682295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}